Evaluation of a novel liquid biopsy-based ColoScape assay for mutational analysis of colorectal neoplasia and triage of FIT+ patients: a pilot study

作者: Silvana Russo Spena , Farah Patell-Socha , Qing Sun , Michael J Powell , Umberto Malapelle

DOI: 10.1136/JCLINPATH-2018-205412

关键词: KRASPopulation studyInternal medicineCancerColonoscopyOncologyTriageClinical trialLiquid biopsyColorectal cancerMedicine

摘要: Circulating cell free tumour derived nucleic acids are becoming recognised as clinically significant and extremely useful biomarkers for detection of cancer monitoring the progression targeted drug therapy immunotherapy. Screening programmes colorectal in Europe use Fetal Immunochemical Test (FIT) test a primary screener. FIT+ patients referred to immediate colonoscopy positive predictive value (PPV) is usually 25%. In this article, we report study employing ColoScape assay panel detect mutations APC, KRAS, BRAF CTNNB1 genes, order collect preliminary performance indicators plan future, larger population study. The was evaluated on 52 prospectively collected whole-blood samples obtained from enrolled CRC screening programme ASL NAPOLI 3 SUD, using confirmation. assay's sensitivity advanced adenomas 53.8% specificity 92.3%. PPV 70.0% negative predicitive (NPV) 85.7%. Workflow optimisation essential maximise sensitivity. Of note, four six cases missed by had less than suboptimal DNA input (data not shown). Had they been ruled out inadequate, would have increased 69%. However, stated previously, clinical trial, but rather an initial, technical evaluation. conclusion shows that promising tool further studies warranted validate its triage patients.

参考文章(16)
Bettina Scholtka, Mandy Schneider, Ralph Melcher, Tiemo Katzenberger, Daniela Friedrich, Kornelia Berghof-Jäger, Wolfgang Scheppach, Pablo Steinberg, A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans Cancer Epidemiology. ,vol. 33, pp. 123- 129 ,(2009) , 10.1016/J.CANEP.2009.05.001
Bert Vogelstein, Eric R Fearon, Stanley R Hamilton, Scott E Kern, Ann C Preisinger, Mark Leppert, Yusuke Nakamura, Ray White, Alida MM Smits, Johannes L Bos, Genetic alterations during colorectal-tumor development. The New England Journal of Medicine. ,vol. 319, pp. 525- 532 ,(1988) , 10.1056/NEJM198809013190901
Thomas F. Imperiale, David F. Ransohoff, Steven H. Itzkowitz, Theodore R. Levin, Philip Lavin, Graham P. Lidgard, David A. Ahlquist, Barry M. Berger, Multitarget Stool DNA Testing for Colorectal-Cancer Screening The New England Journal of Medicine. ,vol. 370, pp. 1287- 1297 ,(2014) , 10.1056/NEJMOA1311194
Mandy Schneider, Bettina Scholtka, Uwe Gottschalk, Siegbert Faiss, Daniela Schatz, Kornelia Berghof-Jäger, Pablo Steinberg, Detection of up to 65% of Precancerous Lesions of the Human Colon and Rectum by Mutation Analysis of APC, K-Ras, B-Raf and CTNNB1. Cancers. ,vol. 3, pp. 91- 105 ,(2010) , 10.3390/CANCERS3010091
Margreet Lüchtenborg, Matty P Weijenberg, Petra A Wark, A Merdan Saritas, Guido MJM Roemen, Goos NP van Muijen, Adriaan P de Bruïne, Piet A van den Brandt, Anton FPM de Goeij, Mutations in APC , CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study BMC Cancer. ,vol. 5, pp. 160- 160 ,(2005) , 10.1186/1471-2407-5-160
Bert Vogelstein, Kenneth W. Kinzler, Patrice J. Morin, Andrew B. Sparks, Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer Cancer Research. ,vol. 58, pp. 1130- 1134 ,(1998)
Meagan B. Myers, Malathi Banda, Karen L. McKim, Yiying Wang, Michael J. Powell, Barbara L. Parsons, Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas. Neoplasia. ,vol. 18, pp. 253- 263 ,(2016) , 10.1016/J.NEO.2016.03.002
Douglas J. Robertson, Jeffrey K. Lee, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas K. Rex, Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. ,vol. 152, pp. 1217- 1237 ,(2017) , 10.1053/J.GASTRO.2016.08.053